Form 4 for KNSA Kiniksa Pharmaceuticals International, plc
Accepted 2022-10-06 00:00:00 ET · period of report 2022-10-04 · accession 0001415889-22-010379 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-10-06 | 2022-10-04 | KNSA | Megna Michael R | CAO | M - OptEx | — | +175 | 7,466 | +2% | — |
| D | 2022-10-06 | 2022-10-04 | KNSA | Megna Michael R | CAO | F - Tax | $14.23 | -52 | 7,414 | -0.7% | -$739.96 |
| D | 2022-10-06 | 2022-10-04 | KNSA | Megna Michael R | CAO | M - OptEx | $0.00 | -175 | 525 | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Share | 2022-10-04 | M | A | 175 | — | 7,466 | D | — | — | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. |
| 2 | Common | Class A Common Share | 2022-10-04 | F | D | 52 | $14.23 | 7,414 | D | — | — | |
| 3 | Derivative | Restricted Share Unit | 2022-10-04 | M | D | 175 | $0.00 | 525 | D | — · — to — | 175 Class A Common Share | (F1) Each Restricted Share Unit (RSU) represents a contingent right to receive one Class A Common Share of the Issuer. (F2) The RSUs vest over a four year period, with 25% of the RSUs vesting on each anniversary of the date of grant, October 4, 2021. |